Unreliable Mycobacterium Chimaera infection-risk information and notification
First to latest report 31 Mar 2021 — 29 Jun 2023
Reports that mention this concern
2
Times this concern has been raised
5
Stated actions linked to this concern
5
What this concern includes
Includes failures in national or coordinated arrangements for assessing, updating, disseminating and applying Mycobacterium Chimaera infection-risk information after relevant cardiac surgery, including risk estimates, clinical guidance, web information, notification thresholds and communication to patients and clinicians.
What is not included
Excludes generic infection-control, cardiothoracic-surgery, consent or postoperative follow-up deficiencies unless they specifically concern Mycobacterium Chimaera infection-risk information or notification.
Excludes diagnosis or treatment failures after accurate and current Mycobacterium Chimaera risk information has been reliably provided.
Excludes unrelated mycobacterial infections, heater-cooler equipment controls and general public-health guidance without a Mycobacterium Chimaera risk-information or notification connection.
Trends
Reports over time
Reports mentioning this concern, over time
Reports about this concern issued each year.
* 2026 is projected from reports observed to 7 Sep 2026.
Most frequent recipients
Most frequent recipients
Reports about this concern sent to each recipient.
College of Clinical Perfusion Scientists1
National Institute for Cardiovascular Outcomes Research1
Public Health England1
Society for Cardiothoracic Surgery in Great Britain and Ireland1
UK Health Security Agency1
Executive agency2
Health professional body1
Health-system partnership1
Reports and published responses 2 reports
See individual reports that have raised this concern, and the actions taken in response
Avon
Concerns raised2
Inconsistency between guidance and evidence on the surgery date from which patients should be notified of Mycobacterium Chimaera infection risk
Failure to notify patients undergoing surgery before January 2013 of Mycobacterium Chimaera infection risk
No linked response statements
No respondent-stated action or position is linked to these concerns in the published data.
City of London
Concerns raised3
Failure to ensure nationally consistent formulation of Mycobacterium Chimaera risk levels
Failure to keep national Mycobacterium Chimaera risk guidance and web information updated
Failure to capture the true incidence of Mycobacterium Chimaera infection
Linked responses
College of Clinical Perfusion Scientists
National Institute for Cardiovascular Outcomes Research
Public Health England
Society for Cardiothoracic Surgery in Great Britain and Ireland
Stated actions An action is something a respondent says it has done, is doing, or plans to do in response to the concern raised.5
College of Clinical Perfusion Scientists and National Institute for Cardiovascular Outcomes Research and Public Health England and Society for Cardiothoracic Surgery in Great Britain and Ireland
Complete and submit an updated M. chimaera infection risk assessment for publication.
College of Clinical Perfusion Scientists and National Institute for Cardiovascular Outcomes Research and Public Health England and Society for Cardiothoracic Surgery in Great Britain and Ireland
Further update the risk estimates and publish them by September 2021.
College of Clinical Perfusion Scientists and National Institute for Cardiovascular Outcomes Research and Public Health England and Society for Cardiothoracic Surgery in Great Britain and Ireland
Cascade updated risk estimates through clinical networks to professionals informing or consenting patients and investigating or diagnosing infections.
College of Clinical Perfusion Scientists and National Institute for Cardiovascular Outcomes Research and Public Health England and Society for Cardiothoracic Surgery in Great Britain and Ireland
Forward requests to NHS England to agree responsibility and a timetable for updating healthcare guidance and NHS website information.
College of Clinical Perfusion Scientists and National Institute for Cardiovascular Outcomes Research and Public Health England and Society for Cardiothoracic Surgery in Great Britain and Ireland
Maintain surveillance capturing all potential M. chimaera cases and publish information on newly diagnosed cases and associated deaths.
Respondent positions A position is what a respondent says about the concern when they do not describe a specific action.3
College of Clinical Perfusion Scientists and National Institute for Cardiovascular Outcomes Research and Public Health England and Society for Cardiothoracic Surgery in Great Britain and Ireland
The risk estimate was not inaccurate because it measured infection risk using data on all reported cases, not only deaths.
Disputes the concernThe respondent disagreed with part of the concern or the basis for it.
College of Clinical Perfusion Scientists and National Institute for Cardiovascular Outcomes Research and Public Health England and Society for Cardiothoracic Surgery in Great Britain and Ireland
NHS England is responsible for updating guidance and the NHS website, so the requests will be forwarded to it.
Redirects responsibilityThe respondent said that another organisation was responsible for deciding or taking action.
College of Clinical Perfusion Scientists and National Institute for Cardiovascular Outcomes Research and Public Health England and Society for Cardiothoracic Surgery in Great Britain and Ireland
Existing surveillance provides a reasonable basis for ongoing risk monitoring, so a revised or alternative investigative method is unnecessary.
Existing arrangements considered sufficientThe respondent said that existing arrangements were sufficient, so no further action was needed.
Actions and positions describe what organisations say in published responses. Implementation is not independently verified.